MB "Grožio injekcijos" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
35,237 |
- |
-3,619 |
-3,619 |
- |
61.37 |
-10.27 |
399 |
4,648 |
3,594 |
1,168 |
2022 |
---|
37,514 |
- |
3,009 |
3,009 |
- |
61.33 |
8.02 |
3,408 |
3,501 |
3,929 |
2,479 |
2023 |
---|
51,187 |
- |
-2,705 |
-2,705 |
- |
64.81 |
-5.28 |
703 |
2,708 |
2,318 |
291 |
Register and
explore Okredo data2023 |
---|
51,187 |
- |
-2,705 |
-2,705 |
- |
64.81 |
-5.28 |
703 |
2,708 |
2,318 |
291 |
Register and
explore Okredo data2023
Turnover (€)
51,187 €36 % *
Sales per employee (€)
-Profit before tax (€)
-2,705 €-190 % *
Net Profit (€)
-2,705 €-190 % *
Profit per employee (€)
-Total profitability (%)
64.81 %5.67 % *
Net profitability (%)
-5.28 %-165.84 % *
Equity (€)
703 €-79 % *
Amounts Payable And Liabilities (€)
2,708 €-23 % *
Non-current Assets (€)
2,318 €-41 % *
CurrentAssets (€)
291 €-88 % *